Neogen Corp (NEOG)

In the past six months, Neogen's stock has experienced significant fluctuations. As of early February 2026, the stock had increased by 46.34% in the past month and 54.51% year-to-date. Over the last 12 months, the stock price increased by 4.15%. The 52-week high for NEOG was $10.96, and the 52-week low was $3.87. A notable event impacting the stock was the company's Q2 2026 earnings report on January 8, 2026, where Neogen posted earnings per share (EPS) of $0.10, exceeding analysts' expectations of $0.06. This beat contributed to a sharp increase in the share price over the past month and 90 days. However, the company has faced challenges related to its 2023 merger with 3M's Food Safety Business, leading to integration issues that undermined financial performance and investor credibility. These challenges resulted in a full-year 2025 net loss of $612.2 million, primarily due to a non-cash goodwill impairment. Analysts have issued various ratings, with an average "Hold" recommendation and an average one-year price target of $10.67 as of February 1, 2026.

Neogen's products and services experience some demand seasonality. The company has noted a lower-than-normal first-half seasonality for its Q1 revenue, with performance improving in September compared to the first month of the quarter. Additionally, the food testing equipment and kits industry, in which Neogen operates, has experienced an industry-wide demand slowdown, partly attributed to a decrease in urgency following the COVID health-scare period.

Neogen Corporation is an international food and animal safety company that develops, manufactures, and markets diagnostic test kits and related products. The company operates within the biotechnology and diagnostics sectors, focusing on enhancing safety and quality across the food chain. Neogen's major products include diagnostic test kits for detecting foodborne pathogens, natural toxins, allergens, drug residues, and spoilage organisms in food production. In the animal safety sector, Neogen offers products for animal health diagnostics, veterinary instruments, pharmaceuticals, and biosecurity solutions. The company also provides genomics research products focused on gene isolation and heredity mapping, including genotyping and next-generation sequencing solutions for various animal species. Additionally, Neogen offers expert consulting and training services for food safety management systems, custom test development, and technical support for its products.

Neogen serves a diverse global customer base, including food processors, agricultural producers, veterinarians, and government agencies. The company's geographic footprint spans numerous countries, including Canada, the United States, the United Kingdom, parts of Europe, Mexico, Brazil, India, and China. Approximately half of Neogen's revenue is generated outside the U.S., although a significant portion of its manufacturing operations remains domestic.

In the past year, Neogen's brand reputation has been affected by a putative class action lawsuit filed by shareholders alleging materially false and misleading statements regarding the integration of 3M's Food Safety Division. Operational challenges, including production inefficiencies and shipment delays, particularly in its Food Safety segment, have impacted the company's ability to fulfill orders promptly. Despite these challenges, Neogen's solutions are considered critical in light of recent high-profile foodborne illness outbreaks, underscoring the growing importance of proactive food safety measures.

Neogen Corporation's ownership structure is heavily concentrated among institutional investors, who collectively hold the dominant stake and influence major strategic decisions. Major institutional shareholders include BlackRock, Inc., The Vanguard Group, Inc., Ing Groep Nv, iShares Core S&P Small-Cap ETF, Clarkston Capital Partners, LLC, Gates Capital Management, Inc., State Street Corp, Dimensional Fund Advisors Lp, Mackenzie Financial Corp, and Vanguard Total Stock Market Index Fund Investor Shares. These institutions hold a substantial number of shares, with Vanguard Group Inc. alone holding over 23 million shares as of a recent reporting date. Individual investors and other private entities hold the remaining float.